+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neratinib"

Neratinib Maleate Tablets Market by Indication (Early Stage Breast Cancer, Metastatic Breast Cancer), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Neratinib Maleate Tablets Market by Indication (Early Stage Breast Cancer, Metastatic Breast Cancer), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Dosage Strength, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
TKIs for Breast Cancer Market by Drug (Lapatinib, Neratinib, Pyrotinib), Therapeutic Line (First Line, Later Lines, Second Line), Mechanism Of Action, Distribution Channel, Patient Age Group - Global Forecast 2025-2030 - Product Thumbnail Image

TKIs for Breast Cancer Market by Drug (Lapatinib, Neratinib, Pyrotinib), Therapeutic Line (First Line, Later Lines, Second Line), Mechanism Of Action, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
HER2 Inhibitors Market Report 2025 - Product Thumbnail Image

HER2 Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Breast Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
UAE Breast Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Thumbnail Image

UAE Breast Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • January 2025
  • 82 Pages
  • United Arab Emirates United Arab Emirates
From
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 276 Pages
  • Global
From
Cancer Supportive Care Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Cancer Supportive Care Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Neratinib is an oral, small molecule tyrosine kinase inhibitor used in the treatment of certain types of cancer. It is approved for the treatment of metastatic breast cancer in patients who have previously been treated with trastuzumab and a taxane. It is also approved for the extended adjuvant treatment of early stage HER2-positive breast cancer in patients who have previously been treated with trastuzumab. Neratinib is used to target the HER2 receptor, which is overexpressed in certain types of cancer. Neratinib is a relatively new drug in the oncology market, but it has been gaining traction due to its efficacy in treating certain types of cancer. It is a promising drug for the treatment of HER2-positive breast cancer, and it has the potential to improve outcomes for patients with this type of cancer. Some companies in the Neratinib market include Pfizer, AstraZeneca, and Eisai. Show Less Read more